University Children's Hospital Zürich

Zurich, Switzerland

Description

The University Children’s Hospital in Zurich is not only the largest pediatric hospital in Switzerland but also one of the leading pediatric centers in Europe. The Department of Oncology at the University Children’s Hospital is part of the Comprehensive Cancer Center Zürich and is in very close proximity to the worldly renowned ETH fostering collaborations with one the leading technical universities in the world. The team has extensive experience in clinical trials of all phases.  The DIPG Center of Expertise focuses on translational and early phase clinical research in the field of diffuse-intrinsic pontine glioma and other high-grade gliomas.

Our pediatric brain tumor patients and their families are supported by a multidisciplinary team of neuro-oncologists, neuro-surgeons and radiotherapists, but also specialized nurses, psychologists, and social workers.

Contact information

 

Steinwiesstrasse 75, 8032 Zurich, Switzerland

Team

Principal Investigator
Pediatric Neuro-oncologist
Dr. Gerber is pediatric neuro-oncologist and head of the Early Phase Clinical Trials Unit of the Department of Pediatric Oncology at the University Children’s Hospital of Zürich. He is board certified in pediatric oncology and in pharmaceutical medicine, and he is interested in the development of clinical trials within international collaborative groups and in the evaluation of novel treatment approaches for patients with refractory disease.
Co-Principal Investigator
Pediatric Oncologist
Dr. Ana Guerreiro Stücklin is a pediatric oncologist. After her medical studies at the University of Porto, Portugal, she graduated from the MD-PhD Program at the University of Zurich and completed her pediatric residency at the University Children’s Hospital in Zurich. She was a pediatric hematology/oncology and subsequently neuro-oncology fellow at the Hospital for Sick Children in Toronto until 2018, when she returned to Zurich and joined the Neuro-Oncology Group at the University Children’s Hospital. Her research interests include the study of chemoresistance, metastases and the molecular causes of treatment failure, especially in gliomas and medulloblastomas affecting infants and young children. Additionally, she is interested in the development of new targeted therapies and clinical trials for pediatric brain tumors.